BCR::ABL1 Mutational Profiling in US Patients With Chronic-phase Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
186-198
DOI: 10.21873/cdp.10518
Genetically Optimized Modular Neural Networks for Precision Lung Cancer Diagnosis: Exploratory Study of Novel Approach
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
199-213
DOI: 10.21873/cdp.10519
A Sequential Proteomic Relay Defines a Decade-long Pre-diagnostic Window for Pancreatic Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
214-221
DOI: 10.21873/cdp.10520
Expression of CLDN18.2 in Invasive Mucinous Adenocarcinomas of the Lung
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
222-226
DOI: 10.21873/cdp.10521
Patient-reported Symptoms Differ Between Patients With Brain Metastasis Starting Either Focal Stereotactic Radiotherapy or Whole-brain Radiotherapy
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
227-235
DOI: 10.21873/cdp.10522
Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
236-244
DOI: 10.21873/cdp.10523
Wirsching Psychosocial Risk Scale (WPRS) Versus Outcome in Patients With Breast Disease and Breast Cancer: A Prospective 25-year Follow-up Study in Patients With Breast Cancer Symptoms
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
245-256
DOI: 10.21873/cdp.10524
Prolonged Renal Dysfunction in Patients Undergoing Chemotherapy for Locally Advanced Esophageal Cancer: Treatment Implications and Risk Factors
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
254-264
DOI: 10.21873/cdp.10525
Three-dimensional Conformal Radiation Planning Study for Limited-stage Small-cell Lung Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
265-272
DOI: 10.21873/cdp.10526
Ossification of Mandibular Central Giant Cell Granuloma (CGCG) in Neurofibromatosis Type 1 Patients
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
273-290
DOI: 10.21873/cdp.10527
Postoperative Outcomes and Strategic Refinement in Intraductal Papillary Mucinous Neoplasm Management: A Single Academic Cancer Center Experience
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
291-302
DOI: 10.21873/cdp.10528
Real-world Treatment Selection and Shared Decision-making in De Novo Metastatic Castration-sensitive Prostate Cancer in Japan
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
303-313
DOI: 10.21873/cdp.10529
Minimally Invasive Colectomy Contributes to Decreasing Postoperative Morbidity in Patients With High Naples Prognostic Score
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
314-321
DOI: 10.21873/cdp.10530
Immunohistochemical Expression of Endoplasmic Reticulum Stress Markers and their Association With Clinicopathological Characteristics and Survival Outcomes in Endometrial Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
322-334
DOI: 10.21873/cdp.10531
Immune Network Construction and Prognostic Evaluation of Checkpoint Genes in Endometrial Cancer Using STRING, MCODE, and GEPIA2
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
335-349
DOI: 10.21873/cdp.10532
Clinical Outcomes of Adrenalectomy for Metastatic Adrenal Tumor: A 30-case Single-center Study
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
350-358
DOI: 10.21873/cdp.10533
Development of Second Primary Malignancies in Long-term Survivors of Unresectable Esophageal Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
359-367
DOI: 10.21873/cdp.10534
Diagnostic Challenge of a Tumor-mimicking Spinal Pseudogout Lesion: Case Report and Literature Review
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
368-375
DOI: 10.21873/cdp.10535
Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
376-382
DOI: 10.21873/cdp.10536
The Prognostic Role of Inflammation on Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
6(2):
383-392
DOI: 10.21873/cdp.10537